Published in Medical Letter on the CDC and FDA, February 11th, 2001
Among women receiving their first National Breast and Cervical Cancer Early Detection Program (NBCCEDP)-funded Papanicolau (Pap) test between 1991 and 1998, American-Indian or Alaska-Native (AI/AN) women had the highest proportion of abnormal tests (4.4%), followed by African Americans (3.2%), whites (3.0%), Hispanics (2.7%), and Asians/Pacific Islanders (A/PI) (1.9%).
White women had the highest rate of serious cervical lesions detected by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.